Metadata record for the manuscript: Effects of systemic inflammation on relapse in early breast cancer

<b>Summary</b><br> This metadata record provides details of the data supporting the claims of the related manuscript: “Effects of systemic inflammation on relapse in early breast cancer”. The data consist of a single data spreadsheet in Stata and open format, and a supporting data dictionary in <b>.txt</b> format. The related study aimed to assess whether or not elevated serum inflammatory biomarkers (C-Reactive protein [CRP], interleukin-6 [IL-6], and serum amyloid A [SAA]) and/or the presence of a high-risk IL-6 promoter genotype were associated with recurrence of hormone receptor positive (HR+) early breast cancer.<br> <b> </b> <b>Data access</b> The data generated and/or analysed during the related study is openly available as part of this metadata record. The data are as follows:- <b>WABC Case Control Deidentified Dataset.xlsx</b> – De-identified dataset for WABC-II Case Control population with serum and genomic biomarkers as well as outcomes.- <b>WABC Case Control Deidentified Dataset.dta</b> – Stata version of the above.- <b>WABC_data_dictionary.txt</b> – Data dictionary to support the above files. <b><br></b><b>Name of Institutional Review Board or ethics committee that approved the study</b> This study was approved by the Institutional Review Board of the University of Pennsylvania and all study procedures were conducted according to the institution’s code of ethics.